SunStates Fund

SunStates Fund, formally known as MPM SunStates Fund, L.P., operates as a venture capital entity under MPM Asset Management LLC. It specializes in early-stage investment across the life science sector, strategically acquiring minority stakes in biotechnology and healthcare enterprises. The fund aims to foster innovation and develop novel solutions for critical medical fields.

MPM Asset Management LLC, the fund's managing firm, was co-founded by Ansbert Gadicke in 1997. Its genesis stemmed from an insightful belief in the potential of nascent biotechnology and healthcare innovations. The firm’s commitment involves identifying and nurturing scientific breakthroughs into viable enterprises, a principle guiding the strategic direction of investment vehicles like SunStates Fund.

SunStates Fund primarily supports innovative startups and growth-stage companies developing therapies, diagnostics, and medical technologies within the life sciences. The fund’s vision is to catalyze transformative advancements in medicine, ultimately improving patient outcomes and shaping the future of global health.